Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. D. da Fonseca · SciRah

Researcher profile · Semantic Scholar

L. D. da Fonseca

Share profile

L. D. da Fonseca — researcher profile on SciRah

h-index: 18
Works: 138
Citations: 1,548

Most-cited papers

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial.
T. Yau, P. Galle, T. Decaens, B. Sangro +24 more
2025The Lancet306 citations Open access
Semantic Scholar
Insights into the success and failure of systemic therapy for hepatocellular carcinoma
J. Bruix, L. D. da Fonseca, M. Reig
2019Nature reviews: Gastroenterology & hepatology180 citations Open access
Semantic Scholar
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
J. Banales, Pedro M. Rodrigues, S. Affò, J. B. Andersen +143 more
2025Nature reviews: Gastroenterology & hepatology93 citations Open access
Semantic Scholar
Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study
Manuel de la Torre-Aláez, A. Matilla, M. Varela, M. Iñarrairaegui +12 more
2022Journal for ImmunoTherapy of Cancer78 citations Open access
Semantic Scholar
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
Sergio Muñoz-Martínez, V. Sapena, A. Forner, J. Nault +81 more
2021JHEP Reports56 citations Open access
Semantic Scholar
Controversies in the management of hepatocellular carcinoma
A. Forner, L. D. da Fonseca, Á. Díaz-González, M. Sanduzzi-Zamparelli +2 more
2019JHEP Reports52 citations Open access
Semantic Scholar
Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma.
L. D. da Fonseca, M. Reig, J. Bruix
2020Clinical Liver Disease50 citations
Semantic Scholar
Systematic review with meta‐analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib
Á. Díaz-González, M. Sanduzzi-Zamparelli, V. Sapena, F. Torres +7 more
2019Alimentary Pharmacology and Therapeutics44 citations Open access
Semantic Scholar
Epidemiology of Liver Cancer in Latin America: Current and Future Trends
F. Carrilho, D. Paranaguá-Vezozzo, A. Chagas, Regiane Saraiva de Souza Melo Alencar +1 more
2019Seminars in liver disease (Print)32 citations Open access
Semantic Scholar
Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical Patients.
Á. Díaz-González, R. Vilana, L. Bianchi, Á. García-Criado +7 more
2020Journal of Vascular and Interventional Radiology31 citations
Semantic Scholar
Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study
Sergio Muñoz-Martínez, V. Sapena, A. Forner, J. Bruix +51 more
2022Liver international (Print)23 citations Open access
Semantic Scholar
Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice.
J. Rimola, L. D. da Fonseca, V. Sapena, C. Perelló +15 more
2020European Journal of Radiology22 citations Open access
Semantic Scholar
Hepatic epithelioid hemangioendothelioma: An international multicenter study.
M. Sanduzzi-Zamparelli, J. Rimola, C. Montironi, V. Nunes +13 more
2020Digestive and Liver Disease21 citations
Semantic Scholar
Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC.
F. Piñero, M. Anders, Carla Bermudez, Ezequiel Demirdjian +23 more
2023Annals of Hepatology19 citations Open access
Semantic Scholar
Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association
M. Allaire, L. D. da Fonseca, M. Sanduzzi-Zamparelli, Won-Mook Choi +10 more
2025The Lancet Regional Health - Europe17 citations Open access
Semantic Scholar
Regorafenib in Patients with Antiangiogenic-Naïve and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase 2b Trial.
R. Riechelmann, L. S. Leite, G. Bariani, J. Glasberg +9 more
2019The Oncologist17 citations Open access
Semantic Scholar
Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement
A. Chagas, L. D. da Fonseca, F. Coelho, Lisa Rodrigues da Cunha Saud +12 more
2020Clinics15 citations Open access
Semantic Scholar
Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials
Á. Díaz-González, V. Sapena, L. Boix, M. Brunet +14 more
2020Liver international (Print)13 citations
Semantic Scholar
965MO Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line (1L) treatment for unresectable hepatocellular carcinoma (uHCC): Expanded analyses from CheckMate 9DW
T. Decaens, T. Yau, M. Kudo, B. Sangro +16 more
2024Annals of Oncology12 citations
Semantic Scholar
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis
F. Piñero, M. Anders, Carla Bermudez, Diego Arufe +18 more
2025Liver international (Print)10 citations Open access
Semantic Scholar
Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
L. D. da Fonseca, Raphael L. C. Araújo
2022World Journal of Gastroenterology10 citations Open access
Semantic Scholar
Immunotherapy-Based Treatments of Hepatocellular Carcinoma: AJR Expert Panel Narrative Review.
R. Cannella, Sara C. Lewis, L. D. da Fonseca, M. Ronot +1 more
2022AJR. American journal of roentgenology10 citations
Semantic Scholar
Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)
S. Carvalho, L. Vasconcelos, L. D. da Fonseca, R. F. Carmo +7 more
2021Clinics10 citations Open access
Semantic Scholar
A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes
L. D. da Fonseca, P. Leonardi, P. H. Hashizume, F. Sansone +3 more
2022Clinical and Experimental Hepatology9 citations Open access
Semantic Scholar
Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
G. Marta, L. D. da Fonseca, M. Braghiroli, F. Moura +2 more
2021Clinics9 citations Open access
Semantic Scholar
Trial eligibility in advanced hepatocellular carcinoma: Does it support clinical practice in underrepresented subgroups?
F. Piñero, L. D. da Fonseca
2021World Journal of Gastroenterology9 citations Open access
Semantic Scholar
Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line (1L) therapy for unresectable hepatocellular carcinoma (uHCC): CheckMate 9DW expanded analyses.
Masatoshi Kudo, T. Yau, T. Decaens, B. Sangro +16 more
2025Journal of Clinical Oncology8 citations
Semantic Scholar
Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence
L. D. da Fonseca, P. H. Hashizume, Irai S. de Oliveira, L. Izquierdo-Sánchez +8 more
2022Cancers8 citations Open access
Semantic Scholar
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma
J. Corominas, V. Sapena, M. Sanduzzi-Zamparelli, Cristina Millán +10 more
2021Cancers8 citations Open access
Semantic Scholar
"Hepatocellular carcinoma Surveillance: Current challenges in Latin America".
J. Pages, M. Mendizabal, Graciela Castro-Narro, J. M. Menéndez +6 more
2025Annals of Hepatology7 citations Open access
Semantic Scholar
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy
Marta Fortuny, L. D. da Fonseca, M. Allaire, Rocío Sánchez +25 more
2025Liver international (Print)7 citations Open access
Semantic Scholar
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes
L. D. da Fonseca, L. Izquierdo-Sánchez, P. H. Hashizume, Yanina Carlino +17 more
2024The Lancet Regional Health - Americas7 citations Open access
Semantic Scholar
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy
F. Knebel, L. Barber, Alice Newey, D. Kleftogiannis +12 more
2020Cancers6 citations Open access
Semantic Scholar
Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics
L. D. da Fonseca, Victor Junji Yamamoto, Mateus Trinconi Cunha, G. S. Torre +7 more
2023Journal of Hepatocellular Carcinoma5 citations Open access
Semantic Scholar
Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma—ready for their use?
L. D. da Fonseca, A. Forner
2021Alimentary Pharmacology and Therapeutics5 citations Open access
Semantic Scholar
Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma
L. D. da Fonseca, F. Piñero, M. Anders, Carla Bermudez +16 more
2025OncoTarget4 citations
Semantic Scholar
148O Overall evaluation of health-related quality of life (HRQoL) and efficacy assessment in patients (pts) who discontinued (d/c) due to treatment-related adverse events (TRAEs): Results from CheckMate 9DW
B. Sangro, T. Decaens, P. Galle, M. Kudo +16 more
2025Annals of Oncology4 citations
Semantic Scholar
Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion
L. Kulik, L. D. da Fonseca, A. He, J. Rimola +3 more
2020Journal of Hepatocellular Carcinoma4 citations Open access
Semantic Scholar
Effectiveness and Safety of Immunotherapy for Hepatocellular Carcinoma in Clinical Practice: A Brazilian Multicenter Study.
L. D. da Fonseca, C. Freire, R. Guedes, M. Lyra +13 more
2025JCO Global Oncology3 citations Open access
Semantic Scholar
Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series
Regiane Saraiva de Souza Melo Alencar, C. Oliveira, A. Chagas, L. D. da Fonseca +8 more
2022Clinics3 citations Open access
Semantic Scholar
Adherence and quality are key for a beneficial HCC surveillance
L. D. da Fonseca, A. Forner
2020Liver international (Print)3 citations Open access
Semantic Scholar
Can thrombotic events be a major concern in hepatocellular carcinoma patients under systemic treatment during SARS‐Cov‐2?
L. D. da Fonseca, F. Carrilho
2020Liver international (Print)3 citations Open access
Semantic Scholar
Updates in immunotherapy for hepatocellular carcinoma
L. D. da Fonseca, Flair Carrilho
2019Hepatoma Research3 citations Open access
Semantic Scholar
GS-005 Outcomes by liver function in patients with unresectable hepatocellular carcinoma treated with nivolumab plus ipilimumab vs lenvatinib or sorafenib in the CheckMate 9DWtrial
Bruno Sangro, M. Kudo, T. Decaens, Matthias Pinter +16 more
2025Journal of Hepatology2 citations
Semantic Scholar
Fibrolamellar hepatocellular carcinoma: Advances, challenges and opportunities in a rare malignancy
L. D. da Fonseca, Raphael L. C. Araujo
2025World Journal of Gastrointestinal Surgery2 citations
Semantic Scholar
Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment
L. D. da Fonseca, L. Uratani, G. Soares, P. S. Do Amaral +4 more
2023Molecular and clinical oncology2 citations Open access
Semantic Scholar
Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs
Á. Díaz-González, V. Sapena, L. Boix, F. Torres +13 more
2021United European Gastroenterology journal2 citations Open access
Semantic Scholar
Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activity
L. D. da Fonseca, Carla Fuster-Anglada, C. Carrera, Cristina Millán +10 more
2021OncoTarget2 citations Open access
Semantic Scholar
An infectious etiology of esophageal cancer spreading from endemic to non-endemic areas.
L. D. da Fonseca, P. H. Hashizume
2020Gastroenterology & hepatology2 citations
Semantic Scholar
Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (HCC): 4-year follow-up of CheckMate 9DW.
P. Galle, B. Sangro, T. Decaens, Masatoshi Kudo +13 more
2026Journal of Clinical Oncology1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Reig×14
Invite
M. Reig — researcher profile on SciRah
J. Bruix×12
Invite
J. Bruix — researcher profile on SciRah
A. Forner×12
Invite
A. Forner — researcher profile on SciRah
M. Sanduzzi-Zamparelli×11
Invite
M. Sanduzzi-Zamparelli — researcher profile on SciRah

×9

Invite

V. Sapena — researcher profile on SciRah

Invite

T. Decaens — researcher profile on SciRah

Invite

G. Pizarro — researcher profile on SciRah

Invite

F. Piñero — researcher profile on SciRah

Á. Díaz-González×6

Invite

Á. Díaz-González — researcher profile on SciRah

Invite

F. Carrilho — researcher profile on SciRah

Invite

J. Rimola — researcher profile on SciRah

Invite

B. Sangro — researcher profile on SciRah